Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group
Open Access
- 23 September 2014
- Vol. 121 (3), 467-475
- https://doi.org/10.1002/cncr.29065
Abstract
BACKGROUND Patients with Ewing sarcoma require local primary tumor control with surgery, radiation, or both. The optimal choice of local control for overall and local disease control remains unclear. METHODS Patients with localized Ewing sarcoma of bone who were treated on 3 consecutive protocols with standard‐dose, 5‐drug chemotherapy every 3 weeks were included (n=465). Propensity scores were used to control for differences between local control groups by constructing multivariate models to assess the impact of local control type on clinical endpoints (event‐free survival [EFS], overall survival, local failure, and distant failure) independent of differences in their propensity to receive each local control type. RESULTS Patients who underwent surgery were younger (P=.02) and had more appendicular tumors (P<.001). Compared with surgery, radiation had higher unadjusted risks of any event (hazard ratio [HR], 1.70; 95% confidence interval [CI], 1.18‐2.44), death (HR, 1.84; 95% CI, 1.18‐2.85), and local failure (HR, 2.57; 95% CI, 1.37‐4.83). On multivariate analysis, compared with surgery, radiation had a higher risk of local failure (HR, 2.41; 95% CI, 1.24‐4.68), although there were no significant differences in EFS (HR, 1.42; 95% CI, 0.94‐2.14), overall survival (HR, 1.37; 95% CI, 0.83‐2.26), or distant failure (HR, 1.13; 95% CI, 0.70‐1.84) between local control groups. CONCLUSIONS In this large group of similarly treated patients, choice of the mode of local control was not related significantly to EFS, overall survival, or distant failure, although the risk of local failure was greater for radiation compared with surgery. These data support surgical resection when appropriate, whereas radiotherapy remains a reasonable alternative in selected patients. Cancer 2015;121:467–475. © 2014 American Cancer Society.Keywords
Funding Information
- American Society of Clinical Oncology
- National Institutes of Health (1K23CA154530)
- National Institutes of Health (U10 CA98543)
- Daniel P. Sullivan Fund
- Frank A. Campini Foundation
- Nick Currey Fund
- QuadW foundation
This publication has 20 references indexed in Scilit:
- Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group StudyJournal of Clinical Oncology, 2009
- Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976Cancer, 2008
- Local Control in Pelvic Ewing Sarcoma: Analysis From INT-0091—A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2006
- Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapyCancer, 2006
- Limb sparing surgery for pediatric musculoskeletal tumorsPediatric Blood & Cancer, 2004
- Ewing sarcoma: Radiation dose and target volumePediatric Blood & Cancer, 2004
- Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of BoneThe New England Journal of Medicine, 2003
- Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcomaEuropean Journal of Cancer, 1999
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958